UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021097
Receipt number R000024203
Scientific Title A clinical study for evaluating the effects of lactic acid bacteria FK-23 on controlling intestinal functions (improvement of bowel movement)
Date of disclosure of the study information 2016/05/31
Last modified on 2019/02/21 13:04:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A clinical study for evaluating the effects of lactic acid bacteria FK-23 on controlling intestinal functions (improvement of bowel movement)

Acronym

A clinical study for evaluating the effects of lactic acid bacteria FK-23 on controlling intestinal functions (improvement of bowel movement)

Scientific Title

A clinical study for evaluating the effects of lactic acid bacteria FK-23 on controlling intestinal functions (improvement of bowel movement)

Scientific Title:Acronym

A clinical study for evaluating the effects of lactic acid bacteria FK-23 on controlling intestinal functions (improvement of bowel movement)

Region

Japan


Condition

Condition

Healthy volunteers

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of 2-week intake of lactic acid bacteria FK-23 on controlling intestinal functions in healthy volunteers with a tendency to be constipated

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Defecation frequency

Key secondary outcomes

Population of bifidobacterium to total bacteria, feeling after defecation, smell of feces, defecation days, fecal condition


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Powder food containing FK-23 (0.25 g)

Interventions/Control_2

Powder food containing FK-23 (0.075 g)

Interventions/Control_3

Powder food containing FK-23 (0.025 g)

Interventions/Control_4

Powder food not containing FK-23 (placebo)

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Healthy subject within 20-65 years of age, both genders, with constipation tendency (with defecation frequency from 3 to 5 times per week)
2)Subject having a briefing of the content of the present study, fully understanding and agreeing to its objective and being able to personally sign a written informed consent

Key exclusion criteria

1)Subject receiving treatment for gastrointestinal diseases
2)Subject having a medical history with organic constipation or irritable bowel syndrome
3)Subject taken medicines for intestinal disorder or laxatives
4)Subject taking medicine, quasi-drugs, food for specified health uses or foods with functional claims having the effects for intestinal functions
5)Subject having serious liver diseases, cardiovascular, respiratory, endocrine or metabolic disorders, or having a medical history with them
6)Subject have a medical history with test food-ralated allergy
7)Female subject who is pregnant or lactating, or intending to become pregnant during the study
8)Subject who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study
9)Subject deemed unsuitable by the investigator

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Osami Kajimoto

Organization

Osaka City University Graduate School of Medicine

Division name

Department of Medical Science on Fatigue

Zip code


Address

1-4-3 Asahi-machi, Abeno-ku, Osaka

TEL

06-6645-6171

Email

kajimoto@med.osaka-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomohiro Sugino

Organization

Soiken Inc.

Division name

R&D Division

Zip code


Address

Senri Life Science Center 13F, 1-4-2, Shinsenri-higashimachi, Toyonaka, Osaka

TEL

06-6871-8888

Homepage URL


Email

sugino@soiken.com


Sponsor or person

Institute

Soiken Inc.

Institute

Department

Personal name



Funding Source

Organization

Nichinichi Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 12 Month 19 Day

Date of IRB


Anticipated trial start date

2016 Year 02 Month 20 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 02 Month 19 Day

Last modified on

2019 Year 02 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024203


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name